Showing results (221-230 of 266) with videos related to
Sort By:
Pageof 27
Scientific Reports|January 28, 2017
Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cellsN-I Zahaf, A E Lang, L Kaiser, et al.Journal of Neurology|October 20, 1999
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degenerationI Litvan, D A Grimes, A E Lang, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 12, 2012
Associated movement disorders in orthostatic tremorTiago A Mestre, Anthony E Lang, A E Lang, et al.Brain : a Journal of Neurology|April 7, 2009
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET studyT D L Steeves, J Miyasaki, M Zurowski, et al.Journal of Neurology|October 20, 1999
Posteroventral medial pallidotomy in Parkinson's diseaseA E Lang, J Duff, J A Saint-Cyr, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessmentC G Goetz, G T Stebbins, H M Shale, et al.European Journal of Neurology|March 11, 2020
Opinions and clinical practices related to diagnosing and managing functional (psychogenic) movement disorders: changes in the last decadeK LaFaver, A E Lang, J Stone, et al.Brain : a Journal of Neurology|March 27, 1999
Relationship of lesion location to clinical outcome following microelectrode-guided pallidotomy for Parkinson's diseaseR E Gross, W J Lombardi, A E Lang, et al.Neurology|January 31, 2007
Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson diseaseA Sailer, D I Cunic, G O Paradiso, et al.Neurology|June 28, 2006
Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: a randomized controlled studyR B Postuma, A J Espay, C Zadikoff, et al.Pageof 27